Market Overview

5 Stocks Moving In Wednesday's After-Hours Session: Earnings, Sympathy Moves And Offerings


U.S. markets closed up on Wednesday, with major indexes posting gains of roughly 0.3 percent, helped by higher oil prices and a lower U.S. dollar, which sent almost all commodities up. Let’s take a look into some of the stocks seen moving in Wednesday after-hours session.

Restoration Hardware Holdings Inc (NYSE: RH) plummeted more than 15 percent after the bell rang, driven by the announcement of the company’s first quarter results. While revenue of $455.5 million beat the Street’s consensus by $3.36 million, a net loss of $(0.05) per share missed estimates by $0.10. Q2 guidance also fell short of expectations. For the second quarter, management expects revenue of $505 million to $520 million, versus the Street’s $532 million, and EPS of $0.28 to $0.33, below the $0.80 consensus.

Williams-Sonoma, Inc. (NYSE: WSM) was down about 1.1 percent, most likely on the back of Restoration Hardware’s miss.

Tailored Brands Inc (NYSE: TLRD) was up about 1.1 percent  ahead of the announcement of the company’s first quarter results. The Street is modeling EPS of $0.43 on revenue of $845.2 million, down from $0.54 and $885.09 million in the same quarter last year.

Sarepta Therapeutics Inc (NASDAQ: SRPT) lost 1 percent since the market closed, after the company announced a proposed offering of approximately $37.5 million in common stock, to fund “product and commercial development, manufacturing, any business development activities and other general corporate purposes.”

Ocean Rig UDW Inc. (NASDAQ: ORIG) was up more than 2.25 percent. The spike looked like a continuation of the 5.86 percent surge seen during the day, which seemed driven by the rising oil prices.

Posted-In: Earnings News Guidance Commodities Offerings After-Hours Center Markets Movers


Related Articles (ORIG + RH)

View Comments and Join the Discussion!

After-Hours Social Sentiment In Sarepta Suggests Traders May Be Viewing Offering News As A Positive Indication

Studies Demonstrate Lilly's TaltzĀ® (ixekizumab) Maintained or Achieved High Levels of Skin Clearance for Patients with Moderate-to-Severe Plaque Psoriasis through 60 Weeks